PureTech sells shares in Karuna affiliate for $200m
PureTech Health
154.80p
12:40 24/12/24
-1.02%
-1.60p
Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.
FTSE 250
20,571.51
13:00 24/12/24
n/a
n/a
FTSE 350
4,491.87
12:54 24/12/24
n/a
n/a
FTSE All-Share
4,449.61
13:14 24/12/24
n/a
n/a
Pharmaceuticals & Biotechnology
20,055.90
12:54 24/12/24
0.25%
50.73
PureTech Health said it intended to use the cash to fund operations and advance its clinical stage, wholly-owned pipeline.
The company on Thursday said it would still hold a 20.4% stake in Karuna's and a right to royalty payments on net sales of any commercialised product covered by a license granted by PureTech to Karuna.